Literature DB >> 7533735

Nitric oxide synthesis and the effect of aminoguanidine and NG-monomethyl-L-arginine on the onset of diabetes in the spontaneously diabetic BB rat.

G Wu1.   

Abstract

Nitric oxide (NO) synthesis and the effect of aminoguanidine (AG) and NG-monomethyl-L-arginine (NMMA) (inhibitors of NO synthase) on the onset of diabetes were studied in the spontaneously diabetic BB rat. To measure in vivo NO production, 20 male 50-day-old diabetes-prone BB (BBdp) rats and age-matched non-diabetes-prone BB (BBn) rats were individually placed in metabolism cages. The animals had free access to a casein-based semipurified diet and deionized and double-distilled water. Urine excretion was collected every other day for 70 days, and urinary excretion of nitrate was measured as an index of in vivo NO synthesis. The urinary excretion of nitrate was enhanced by 150-200% in BBdp rats 4-6 days before the onset of diabetes, compared with aged-matched BBn rats. There was no difference in urinary excretion of nitrate between BBn rats and those BBdp rats that did not develop diabetes by the age of up to 120 days. To determine a role of NO in the development of spontaneous diabetes, 40-day-old male BBdp rats (30 rats per group) received daily subcutaneous injections of NMMA (acetate salt) (5 mg/kg body wt) or equal amounts of acetate (control) or oral administration of AG (0 or 3 g/l of drinking water) for 80 days. Both NMMA and AG delayed the onset of diabetes in BBdp rats by 13-15 days without altering the rate of incidence of diabetes.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7533735     DOI: 10.2337/diab.44.3.360

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  18 in total

Review 1.  Targeting advanced glycation with pharmaceutical agents: where are we now?

Authors:  Danielle J Borg; Josephine M Forbes
Journal:  Glycoconj J       Date:  2016-07-09       Impact factor: 2.916

Review 2.  The role of interleukin-1 in the pathogenesis of IDDM.

Authors:  T Mandrup-Poulsen
Journal:  Diabetologia       Date:  1996-09       Impact factor: 10.122

3.  Oral administration of interferon tau enhances oxidation of energy substrates and reduces adiposity in Zucker diabetic fatty rats.

Authors:  Carmen D Tekwe; Jian Lei; Kang Yao; Reza Rezaei; Xilong Li; Sudath Dahanayaka; Raymond J Carroll; Cynthia J Meininger; Fuller W Bazer; Guoyao Wu
Journal:  Biofactors       Date:  2013-06-27       Impact factor: 6.113

4.  Effect of supplementation of unprotected or protected arginine to prolific ewes on maternal amino acids profile, lamb survival at birth, and pre- and post-weaning lamb growth.

Authors:  Elisha Gootwine; Alexander Rosov; Tamir Alon; Claire Stenhouse; Katherine M Halloran; Guoyao Wu; Fuller W Bazer
Journal:  J Anim Sci       Date:  2020-11-01       Impact factor: 3.159

5.  Suppressor of cytokine signalling (SOCS)-3 protects beta cells against IL-1beta-mediated toxicity through inhibition of multiple nuclear factor-kappaB-regulated proapoptotic pathways.

Authors:  A E Karlsen; P E Heding; H Frobøse; S G Rønn; M Kruhøffer; T F Orntoft; M Darville; D L Eizirik; F Pociot; J Nerup; T Mandrup-Poulsen; N Billestrup
Journal:  Diabetologia       Date:  2004-12-02       Impact factor: 10.122

6.  Aminoguanidine reduces glomerular inducible nitric oxide synthase (iNOS) and transforming growth factor-beta 1 (TGF-beta1) mRNA expression and diminishes glomerulosclerosis in NZB/W F1 mice.

Authors:  C W Yang; C C Yu; Y C Ko; C C Huang
Journal:  Clin Exp Immunol       Date:  1998-08       Impact factor: 4.330

7.  Antioxidant enzyme activity and mRNA expression in the islets of Langerhans from the BB/S rat model of type 1 diabetes and an insulin-producing cell line.

Authors:  Louise A Sigfrid; James M Cunningham; Neil Beeharry; L A Håkan Borg; Alma L Rosales Hernandez; Carina Carlsson; Adrian J Bone; Irene C Green
Journal:  J Mol Med (Berl)       Date:  2004-03-09       Impact factor: 4.599

8.  Peroxynitrite-induced protein nitration is responsible for renal mitochondrial damage in diabetic rat.

Authors:  J H Liang; Y N Li; J S Qi; X X Jia
Journal:  J Endocrinol Invest       Date:  2009-09-11       Impact factor: 4.256

9.  Protective role of oral antioxidant supplementation in ocular surface of diabetic patients.

Authors:  V Peponis; M Papathanasiou; A Kapranou; C Magkou; A Tyligada; A Melidonis; T Drosos; N M Sitaras
Journal:  Br J Ophthalmol       Date:  2002-12       Impact factor: 4.638

10.  Suppressive effects of a selective inducible nitric oxide synthase (iNOS) inhibitor on pancreatic beta-cell dysfunction.

Authors:  Y Kato; Y Miura; N Yamamoto; N Ozaki; Y Oiso
Journal:  Diabetologia       Date:  2003-07-24       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.